Immunovaccine Signs Agreement for Phase I/II Clinical Trial of DPX-0907 in Breast and Ovarian Cancer Patients
HALIFAX, NOVA SCOTIA--(Marketwire - Jan. 30, 2013) - Immunovaccine Inc. (TSX VENTURE:IMV), a clinical stage vaccine company, today announced the...